Literature DB >> 30582617

Implication of Fusobacterium necrophorum in recurrence of peritonsillar abscess.

S Ahmed Ali1, Kevin J Kovatch1, Josh Smith2, Emily L Bellile3, John E Hanks1, Paul T Hoff1.   

Abstract

OBJECTIVE: Peritonsillar abscess (PTA) is a common infectious complication of pharyngeal infection managed by otolaryngologists and emergency room physicians. Streptococcus and Fusobacterium (e.g., Fusobacterium necrophorum, FN) species are commonly isolated pathogens. The aim of this study was to determine the implication of culture results on abscess recurrence following drainage.
METHODS: Single-institution retrospective review of patients treated at the University of Michigan between 2000 and 2017. Demographic and clinical outcome data were analyzed, including treatment details, culture data, and recurrence.
RESULTS: One hundred fifty-six of the 990 patients in our study developed recurrence of their abscess (16%). The age ranges most susceptible to recurrence included adolescent (22.9%) and young adult groups (17.1%). Recurrent patients were more likely to have experienced acute progression of symptoms (79% vs. 71%, P = 0.03), trismus (67% vs. 55%, P = 0.006), voice changes (65% vs. 57%, P = 0.04), and dysphagia (72% vs. 61%, P = 0.01) compared to nonrecurrent patients. They were also more likely to have clinical lymphadenopathy noted on initial examination (67% vs. 56%, P = 0.009). Culture data was sent for 852 patients (86%). The presence of FN was significantly more prevalent in the recurrent group (P < 0.0001).
CONCLUSION: There is a high observed prevalence of FN species within PTA aspirates in the recurrent PTA population. PTA aspirate should be sent for anaerobic growth to screen for Fusobacterium species. In addition, follow-up and lower threshold for subsequent tonsillectomy should be considered in this at-risk group. LEVEL OF EVIDENCE: 3 Laryngoscope, 129:1567-1571, 2019.
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  zzm321990Fusobacterium necrophorum; zzm321990Streptococcus anginosus; Peritonsillar abscess; intratonsillar abscess; otolaryngology

Mesh:

Year:  2018        PMID: 30582617      PMCID: PMC6581569          DOI: 10.1002/lary.27675

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  21 in total

1.  Peritonsillar abscess: treatment with immediate tonsillectomy - 10 years of experience.

Authors:  Nicolas Albertz; Gonzalo Nazar
Journal:  Acta Otolaryngol       Date:  2012-06-18       Impact factor: 1.494

2.  Prognostic factors and effects of early surgical drainage in patients with peritonsillar abscess.

Authors:  Tomoyasu Tachibana; Yorihisa Orita; Iku Abe-Fujisawa; Yuya Ogawara; Yuko Matsuyama; Aiko Shimizu; Michihiro Nakada; Yasuharu Sato; Kazunori Nishizaki
Journal:  J Infect Chemother       Date:  2014-08-18       Impact factor: 2.211

3.  Fusobacterium necrophorum findings in Denmark from 2010 to 2014 using data from the Danish microbiology database.

Authors:  Steffen Bank; Anders Jensen; Hanne Merete Nielsen; Lena Hagelskjaer Kristensen; Marianne Voldstedlund; Jørgen Prag
Journal:  APMIS       Date:  2016-10-05       Impact factor: 3.205

4.  Peritonsillar abscess: repeated needle aspiration versus incision and drainage.

Authors:  M Wolf; I Even-Chen; J Kronenberg
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-07       Impact factor: 1.547

5.  Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess.

Authors:  T E Klug; J-J Henriksen; M Rusan; K Fuursted; K A Krogfelt; T Ovesen; C Struve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-09       Impact factor: 3.267

Review 6.  The role of Fusobacterium necrophorum in pharyngotonsillitis - A review.

Authors:  Karin Holm; Steffen Bank; Hanne Nielsen; Lena Hagelskjær Kristensen; Jørgen Prag; Anders Jensen
Journal:  Anaerobe       Date:  2016-09-28       Impact factor: 3.331

7.  Peritonsillar abscess. Clinical and microbiologic aspects and treatment regimens.

Authors:  S Savolainen; H R Jousimies-Somer; A A Mäkitie; J S Ylikoski
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-05

Review 8.  Lemierre's syndrome due to Fusobacterium necrophorum.

Authors:  Krutika Kuppalli; Daniel Livorsi; Naasha J Talati; Melissa Osborn
Journal:  Lancet Infect Dis       Date:  2012-05-25       Impact factor: 25.071

9.  Epidemiology, clinical history and microbiology of peritonsillar abscess.

Authors:  E Mazur; E Czerwińska; I Korona-Głowniak; A Grochowalska; M Kozioł-Montewka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-17       Impact factor: 3.267

10.  Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey.

Authors:  L Hagelskjaer Kristensen; J Prag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-11       Impact factor: 3.267

View more
  1 in total

1.  Emphysematous Cholecystitis Secondary to Fusobacterium nucleatum.

Authors:  Anuj Kunadia; Michael B Leong; Karthikram Komanduri; Randa Abdelmasih; Aneta Tarasiuk-Rusek
Journal:  Cureus       Date:  2021-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.